US Patent Issued to BIOBINA on Sept. 29 for "Use of dextromethorphan in combination with CYP2D6 and CYP3A4 enzyme inhibitors for the treatment of pain" (New York Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,235, issued on Sept. 29, was assigned to BIOBINA LLC (New York).

"Use of dextromethorphan in combination with CYP2D6 and CYP3A4 enzyme inhibitors for the treatment of pain" was invented by Robert Taub (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions for treating pain are provided. Methods for treating pain include administering an effective amount of dextromethorphan or a pharmaceutically acceptable salt thereof in combination with a CYP2D6 enzyme inhibitor and a CYP3A4 enzyme inhibitor to a subject in need thereof. Compositions for treating pain that include dextromethorphan or a pharmaceutically acceptable salt th...